Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA, Neuzil KM, Whitney CG, Starkovich P, Dunstan M, Yu O, Nelson JC, Feikin DR, Shay DK, Baggs J, Carste B, Nahm MH, Carlone G. Jackson LA, et al. Among authors: whitney cg. Vaccine. 2005 May 25;23(28):3697-703. doi: 10.1016/j.vaccine.2005.02.017. Vaccine. 2005. PMID: 15882530 Clinical Trial.
Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.
Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF. Feikin DR, et al. Among authors: whitney cg. Vaccine. 2001 Nov 12;20(3-4):545-53. doi: 10.1016/s0264-410x(01)00347-4. Vaccine. 2001. PMID: 11672921 Clinical Trial.
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Whitney CG, et al. N Engl J Med. 2003 May 1;348(18):1737-46. doi: 10.1056/NEJMoa022823. N Engl J Med. 2003. PMID: 12724479 Free article.
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF. Feikin DR, et al. Among authors: whitney cg. Clin Diagn Lab Immunol. 2004 Jan;11(1):137-41. doi: 10.1128/cdli.11.1.137-141.2004. Clin Diagn Lab Immunol. 2004. PMID: 14715560 Free PMC article. Clinical Trial.
Increased prevalence of pediatric pneumococcal serotypes in elderly adults.
Feikin DR, Klugman KP, Facklam RR, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core surveillance/Emerging Infections Program Network. Feikin DR, et al. Among authors: whitney cg. Clin Infect Dis. 2005 Aug 15;41(4):481-7. doi: 10.1086/432015. Epub 2005 Jul 11. Clin Infect Dis. 2005. PMID: 16028155
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC, Starkovich PT, Dunstan M, Carste B, Shay DK, Baggs J, Carlone GM. Jackson LA, et al. Among authors: whitney cg. Vaccine. 2007 May 16;25(20):4029-37. doi: 10.1016/j.vaccine.2007.02.062. Epub 2007 Mar 12. Vaccine. 2007. PMID: 17391816 Clinical Trial.
295 results